gsidgsidgsid
Welcome to the Global Solutions For Infectious Diseases Website
GSID Home Page
About Us
Our Programs
Support GSID
News & Publications
Contact Us

 

Enrollment of volunteers into the PrEPVacc Phase IIb (PV1) clinical trial has started in Uganda. Sites in Tanzania, South Africa and Mozambique to follow soon.
[more]




   

 

 

BBC World Service The Guardian Prep Vacc logo